Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis

Stroke

Volumn 41, Issue 1, 2010, Pages 147-152

  Nagai, Mutsumi ^a   Terao, Satoshi ^a   Yilmaz, Gokhan ^a   Yilmaz, Cigdem E ^a   Esmon, Charles T ^b   Watanabe, Eiju ^c   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Activated protein C; Blood brain barrier; Brain edema; Endothelial protein C receptor; Leukocyte adhesion

Indexed keywords

ACTIVATED PROTEIN C; CD18 ANTIGEN; CYTOKINE; ENDOTHELIAL PROTEIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CELL ADHESION; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ENDOTHELIAL CELL ADHESION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CRANIAL SINUSES; ENZYME ACTIVATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHIL INFILTRATION; PROTEIN C; SIGNAL TRANSDUCTION; SINUS THROMBOSIS, INTRACRANIAL;

EID: 74049086702     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.562983     Document Type: Article

References (35)

1. Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol. 2004;251:11-23.
2. Ducreux D, Oppenheim C, Vandamme X, Dormont D, Samson Y, Rancurel G, Cosnard G, Marsault C. Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. AJNR Am J Neuroradiol. 2001;22:261-268.
3. Keller E, Flacke S, Urbach H, Schild HH. Diffusion-and perfusion-weighted magnetic resonance imaging in deep cerebral venous thrombosis. Stroke. 1999;30:1144-1146.
4. Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH. Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab. 2005;25:226-233.
5. Rother J, Waggie K, van Bruggen N, de Crespigny AJ, Moseley ME. Experimental cerebral venous thrombosis: Evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab. 1996;16:1353-1361.
6. Rottger C, Bachmann G, Gerriets T, Kaps M, Kuchelmeister K, Schachenmayr W, Walberer M, Wessels T, Stolz E. A new model of reversible sinus sagittalis superior thrombosis in the rat: magnetic resonance imaging changes. Neurosurgery. 2005;57:573-580; discussion 573-580.
7. Vosko MR, Rother J, Friedl B, Bultemeier G, Kloss CU, Hamann GF. Microvascular damage following experimental sinus-vein thrombosis in rats. Acta Neuropathol. 2003;106:501-505.
8. Esmon CT. The protein C pathway. Chest. 2003;124:26S-32S.
9. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131:417-430.
10. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109:3161-3172.
11. Cheng T, Petraglia AL, Li Z, Thiyagarajan M, Zhong Z, Wu Z, Liu D, Maggirwar SB, Deane R, Fernandez JA, LaRue B, Griffin JH, Chopp M, Zlokovic BV. Activated protein c inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006;12:1278-1285.
12. Domotor E, Benzakour O, Griffin JH, Yule D, Fukudome K, Zlokovic BV. Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood. 2003;101:4797-4801.
13. Fernandez JA, Xu X, Liu D, Zlokovic BV, Griffin JH. Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model. Blood Cells Mol Dis. 2003;30:271-276.
14. Griffin JH, Zlokovic B, Fernandez JA. Activated protein C: Potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol. 2002; 39:197-205.
15. Griffin JH, Fernandez JA, Liu D, Cheng T, Guo H, Zlokovic BV. Activated protein C and ischemic stroke. Crit Care Med. 2004;32: S247-S253.
16. Guo H, Liu D, Gelbard H, Cheng T, Insalaco R, Fernandez JA, Griffin JH, Zlokovic BV. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;41:563-572.
17. Liu D, Cheng T, Guo H, Fernandez JA, Griffin JH, Song X, Zlokovic BV. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein c. Nat Med. 2004;10:1379-1383.
18. Lo EH. Combination stroke therapy: easy as APC? Nat Med. 2004;10: 1295-1296.
19. Shibata M, Kumar SR, Amar A, Fernandez JA, Hofman F, Griffin JH, Zlokovic BV. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 2001;103:1799-1805.
20. Toltl LJ, Shin LY, Liaw PC. Activated protein C in sepsis and beyond: update 2006. Front Biosci. 2007;12:1963-1972.
21. Li W, Zheng X, Gu J, Hunter J, Ferrell GL, Lupu F, Esmon NL, Esmon CT. Overexpressing endothelial cell protein C receptor alters the hemo-static balance and protects mice from endotoxin. J Thromb Haemost. 2005;3:1351-1359.
22. Fischer S, Gerriets T, Wessels C, Walberer M, Kostin S, Stolz E, Zheleva K, Hocke A, Hippenstiel S, Preissner KT. Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood. 2007;110:2457-2465.
23. Srivastava AK, Gupta RK, Haris M, Ray M, Kalita J, Misra UK. Cerebral venous sinus thrombosis: developing an experimental model. J Neurosci Methods. 2007;161:220-222.
24. Stokes KY, Clanton EC, Bowles KS, Fuseler JW, Chervenak D, Chervenak R, Jennings SR, Granger DN. The role of T-lymphocytes in hypercholesterolemia- induced leukocyte-endothelial interactions. Microcirculation. 2002;9:407-417.
25. Gaber MW, Yuan H, Killmar JT, Naimark MD, Kiani MF, Merchant TE. An intravital microscopy study of radiation-induced changes in permeability and leukocyte-endothelial cell interactions in the microvessels of the rat pia mater and cremaster muscle. Brain Res Brain Res Protoc. 2004;13:1-10.
26. Yuan H, Gaber MW, Boyd K, Wilson CM, Kiani MF, Merchant TE. Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultra-structural changes. Int J Radiat Oncol Biol Phys. 2006;66:860-866.
27. Lemke DM, Hacein-Bey L. Cerebral venous sinus thrombosis. J Neurosci Nurs. 2005;37:258-264.
28. Frerichs KU, Deckert M, Kempski O, Schurer L, Einhaupl K, Baethmann A. Cerebral sinus and venous thrombosis in rats induces long-term deficits in brain function and morphology-evidence for a cytotoxic genesis. J Cereb Blood Flow Metab. 1994;14:289-300.
29. Miyamoto K, Heimann A, Kempski O. Microcirculatory alterations in a mongolian gerbil sinus-vein thrombosis model. J Clin Neurosci. 2001;8 Suppl 1:97-105.
30. Nakase H, Sakaki T, Kempski O. A scanning technique to measure regional cerebral blood flow and oxyhemoglobin level. Neurosurgery. 2001;48:1335-1342; discussion 1342-11333.
31. Ueda K, Nakase H, Miyamoto K, Otsuka H, Sakaki T. Impact of anatomical difference of the cerebral venous system on microcirculation in a gerbil superior sagittal sinus occlusion model. Acta Neurochir (Wien). 2000;142:75-82.
32. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation. 2006; 113:2105-2112.
33. Gavins F, Yilmaz G, Granger DN. The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation. 2007;14:667-681.
34. Zhu L, He P. Fmlp-stimulated release of reactive oxygen species from adherent leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol. 2006;290:H365-H372.
35. Bezuhly M, Cullen R, Esmon CT, Morris SF, West KA, Johnston B, Liwski RS. Role of activated protein c and its receptor in inhibition of tumor metastasis. Blood. 2009;113:3371-3374.